FDA chief defends cooperation with drug companies

05/30/2007 | Forbes

FDA Commissioner Andrew von Eschenbach defended his agency's cooperation with drug companies as important for the development and safety of new drugs. In detailing the agency's work to make drug development faster and more predictable, von Eschenbach said, "This is a collaboration, but it's not just a collaboration with drug companies, it's a collaboration with academia and with other agencies."

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Principal Engineer - Service (US/MI/00/0043/SL) - 14000009CP
Abbott
Chicago, IL
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC